A randomised, placebo-controlled, singleblind study to characterise the biomarker effects of the CSF-1 receptor antagonist JNJ- 40346527 in participants with mild cognitive impairment | C4C
This research aims to develop new treatments for people suffering from long term depression. The treatment is called DIALOG+ and involves introducing a tablet computer into the regular treatment sessions between patients and their clinician. The aim is to help enhance the communication between patient and clinician so that they can together develop a plan that will improve the patients’ mental health care outcomes